Evidence map›Paper›PMID 26575630›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer.

Francesca Bersani, Eunjung Lee, Peter V Kharchenko, Andrew W Xu, Mingzhu Liu, Kristina Xega, Olivia C MacKenzie, Brian W Brannigan, Ben S Wittner, Hyunchul Jung and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Satellite DNAs in Drosophila koepferae (repleta group) reveal patterns of origin, chromosomal organization, transcription, and turnover in the buzzatii cluster.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Modeling the Copy Number of HSATII Repeats in Human Pericentromere.International journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Francesca BersaniMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Eunjung LeeCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115;
Peter V KharchenkoCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115; Hematology/Oncology Program, Children's Hospital, Boston, MA 02115;
Andrew W XuCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Mingzhu LiuMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Howard Hughes Medical Institute, Chevy Chase, MD 20815;
Kristina XegaMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Olivia C MacKenzieMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Brian W BranniganMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Ben S WittnerMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Hyunchul JungSamsung Medical Center, Seoul 135-710, Korea;
Sridhar RamaswamyMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114;
Peter J ParkCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115; Informatics Program, Children's Hospital, Boston, MA 02115;
Shyamala MaheswaranMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114.
David T TingMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114; dting1@mgh.harvard.edu dhaber@mgh.harvard.edu.
Daniel A HaberMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Howard Hughes Medical Institute, Chevy Chase, MD 20815; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114; dting1@mgh.harvard.edu dhaber@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · USBrigham and Women's Hospital · USCenter for Systems Biology · USSamsung Medical Center · KR

Funding

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsR01CA129933 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel A. Haber · 2008 to 2026
$7.5M
Howard Hughes Medical InstituteNCI NIH HHS K12 CA087723NCI NIH HHS K12CA087723-11A1NCI NIH HHS R01 CA129933NCI NIH HHS R01CA129933
6 · The paper itself

Abstract

Aberrant transcription of the pericentromeric human satellite II (HSATII) repeat is present in a wide variety of epithelial cancers. In deriving experimental systems to study its deregulation, we observed that HSATII expression is induced in colon cancer cells cultured as xenografts or under nonadherent conditions in vitro, but it is rapidly lost in standard 2D cultures. Unexpectedly, physiological induction of endogenous HSATII RNA, as well as introduction of synthetic HSATII transcripts, generated cDNA intermediates in the form of DNA/RNA hybrids. Single molecule sequencing of tumor xenografts showed that HSATII RNA-derived DNA (rdDNA) molecules are stably incorporated within pericentromeric loci. Suppression of RT activity using small molecule inhibitors reduced HSATII copy gain. Analysis of whole-genome sequencing data revealed that HSATII copy number gain is a common feature in primary human colon tumors and is associated with a lower overall survival. Together, our observations suggest that cancer-associated derepression of specific repetitive sequences can promote their RNA-driven genomic expansion, with potential implications on pericentromeric architecture.

Indexed as

Repetitive Sequences, Nucleic AcidCentromereColorectal NeoplasmsDNA, SatelliteHumansNeoplasmsNucleic Acid HybridizationRNADNA, SatelliteRNAcancerrepeatsreverse transcriptionsatellites

Identifiers

PMID26575630
PMCPMC4679016
OpenAlexW2255688436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.